Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
While not among the common side effects in clinical trials, some individuals may experience dizziness, particularly during the initial weeks of treatment or following dose escalation
Cancer 1878 , 188900 (2023)
Because of these risks, doctors may choose to prescribe very small doses of GLP-1s to people with type 1 diabetes, especially if they do not have a lot of weight to lose
Medi-Cal will continue to cover GLP-1s when used for FDA-approved, non-weight-loss indications (e.g., type 2 diabetes, ASCVD, CKD) with appropriate ICD-10 codes and, when required, prior authorization
Furthermore, the article underscores the potential health benefits of semaglutide in weight management, as well as the financial implications of using HSA funds for such treatments
